NCT07405476 2026-04-17Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent TreatmentEmory UniversityPhase 2 Recruiting38 enrolled
NCT04704661 2026-04-13Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialNational Cancer Institute (NCI)Phase 1 Recruiting51 enrolled